VEGFA and neoplasm: Haet et al. have reported that elaiophylin can inhibit tumor cell-induced angiogenesis in in vitro and in vivo models by downregulating the expression of vascular endothelial growth factor (VEGF) and inhibiting hypoxia-inducible factor-1α (HIF-1α) accumulation in human umbilical vein endothelial cells [5].